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The human transporters for the inhibitory neurotrans-
mitter gamma-aminobutyric acid (GABA) hGAT-1, 2,
and 3, and hBGT-1 belong to the neurotransmitter-
sodium symporter (NSS) family of membrane transport
proteins. hGAT-1 has been a target for the design of
antiepileptic therapeutics [1], with tiagabine (Gabitril
®)
being the only GAT inhibitor on the market. The lack
of specific inhibitors for the other hGAT subtypes,
results from a still missing detailed understanding of the
molecular basis of drug-transporter interactions of the
respective subtypes.
We aim at elucidating plausible binding modes for
ligands of each subtype, respectively. In our first studies,
we built up homology models for hGAT-1 in the
occluded and outward-facing conformation based on the
respective high resolution structures of the leucine
transporter of Aquifex aeolicus (LeuT) (pdb-codes: 2A65
and 3F3A). Afterwards, the natural substrate GABA was
docked into the occluded state model and tiagabine into
the outward-facing model by making use of the Induced
Fit Docking module of Schrödinger, LLC. Both models
were further subject to extensive Molecular Dynamics
(MD) simulation studies (GROMACS 4.5.3 was used).
By the aid of MD simulations we could detect the
existence of conserved water molecules into the GABA
(occluded) and tiagabine (open-to-out) binding sites,
respectively. Average structures from the equilibrated
trajectories were extracted and subsequently served for
further docking experiments.
Docking of small ligands (GABA, Guvacine and R-/S
Nipecotic Acid) into the occluded state model nicely
indicated their preference to bind in an extended con-
formation (also demonstrated by long-term MD with
GABA). MD and Docking of tiagabine and analogues
into the open-to-out state model revealed a common
binding mode.
Additionally, our studies will be extended to the other
hGAT subtypes so as to elucidate the secret of subtype
selectivity of GABA Transporters.
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